Alkem labs successfully completes USFDA inspection for Taloja Bioequivalence Center
Mumbai: Alkem Laboratories Ltd. has recently announced the successful completion of U.S Food and Drug Administration (USFDA) inspection of its Taloja facility in MaharashtraThe inspection was conducted from 26th July to 28th July 2021."USFDA had conducted a remote and virtual Bio-Analytical inspection of the Company's Bioequivalence Center located at Taloja, Maharashtra from 26th July, 2021...
Login or Register to read the full article
Mumbai: Alkem Laboratories Ltd. has recently announced the successful completion of U.S Food and Drug Administration (USFDA) inspection of its Taloja facility in Maharashtra
The inspection was conducted from 26th July to 28th July 2021.
"USFDA had conducted a remote and virtual Bio-Analytical inspection of the Company's Bioequivalence Center located at Taloja, Maharashtra from 26th July, 2021 to 28th July, 2021," Alkem said in a filing.
"At the end of the inspection, no Form 483 was issued," it added.
Established in 1973 and headquartered in Mumbai, Alkem is a Indian pharmaceutical company with global operations, engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products.
The Company produces branded generics, generic drugs, active pharmaceutical ingredients (APIs) and nutraceuticals, which it markets in India and International markets.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd